Recent interest in colchicine ( Lodoco ) emerges from its potential to reduce cardiovascular (CV) risk due to its anti-inflammatory properties. Origi…
As cardiovascular pharmacists, the ongoing debate regarding the necessity of aiming for specific low-density lipoprotein (LDL) goals is crucial. Trad…